Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12.
Credit: ABC 10 News | San Diego Duration: 02:12Published
Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12.